Skip to content

WhiteLab Genomics

YC W22 · Active · Unleashing the potential of DNA and RNA based therapies using AI

Competitors

Adjacent

Also from W22 in AI

All of W22

About WhiteLab Genomics

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

YC batch
W22 · Winter 2022
Status, per YC
Active
Category
AI
Team size
40
Location
Paris, Île-de-France, France; Boston, MA, USA
Checked
35m ago

YC tags: Artificial Intelligence, Gene Therapy, Cell Therapy, Genomics

WhiteLab Genomics in W22: 398 companies, 44% AI

WhiteLab Genomics: questions

Which YC batch was WhiteLab Genomics in?

WhiteLab Genomics was in Y Combinator's Winter 2022 batch (W22).

Is WhiteLab Genomics still active?

Y Combinator lists WhiteLab Genomics as active.

Where is WhiteLab Genomics based?

WhiteLab Genomics lists Paris, Île-de-France, France; Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.